CCCC241220P00002000 Option on C4 Therapeutics
| CCCC Stock | USD 4.71 0.40 9.28% |
C4 Therapeutics' latest option contracts expiring on 2024-12-20 are carrying combined implied volatility of 2.35 with a put-to-call open interest ratio of 1.63 over 12 outstanding agreements suggesting investors are buying way more puts than calls on contracts expiring on 2024-12-20. The total put volume is at 93.0, with calls trading at the volume of 93.0. This yields a 0.48 put-to-call volume ratio.
Open Interest Against 2024-12-20 Option Contracts
2024-12-20
The chart above shows C4 Therapeutics' distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. C4 Therapeutics' open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for C4 Therapeutics' option, there is no secondary market available for investors to trade.
In The Money vs. Out of Money Option Contracts on C4 Therapeutics
Analyzing C4 Therapeutics' in-the-money options over time can help investors to take a profitable long position in C4 Therapeutics regardless of its overall volatility. This is especially true when C4 Therapeutics' options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money C4 Therapeutics' options could be used as guardians of the underlying stock as they move almost dollar for dollar with C4 Therapeutics' stock while costing only a fraction of its price.
C4 Therapeutics' stock options are financial instruments that give investors the right to buy or sell shares of C4 Therapeutics common stock at a specified price for a given time period. Generally speaking, an option to purchase or sell CCCC stock makes it part of the underlying stock when the option's price is tied to the movement of the underlying stock. If C4 Therapeutics' stock price goes up or down, the stock options follow.
At present, C4 Therapeutics' Stock Based Compensation To Revenue is projected to increase slightly based on the last few years of reporting. C4 Therapeutics In The Money Call Balance
When C4 Therapeutics' strike price is surpassing the current stock price, the option contract against C4 Therapeutics stock is said to be in the money. When it comes to buying C4 Therapeutics' options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on C4 Therapeutics are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.
CCCC Current Options Market Mood
C4 Therapeutics' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps CCCC Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Open Interest
Put-to-Call Volume
Unfortunately, most C4 Therapeutics' options investors are not very successful. C4 Therapeutics' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.
Rule 16 of the current CCCC contract
Base on the Rule 16, the options market is currently suggesting that C4 Therapeutics will have an average daily up or down price movement of about 0.15% per day over the life of the 2024-12-20 option contract. With C4 Therapeutics trading at USD 4.71, that is roughly USD 0.006918. If you think that the market is fully incorporating C4 Therapeutics' daily price movement you should consider buying C4 Therapeutics options at the current volatility level of 2.35%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
CCCC |
Purchasing C4 Therapeutics options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" CCCC calls. Remember, the seller must deliver C4 Therapeutics stock to the call owner when a call is exercised.
C4 Therapeutics Option Chain
When C4 Therapeutics' strike price is surpassing the current stock price, the option contract against C4 Therapeutics stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
C4 Therapeutics' option chain is a display of a range of information that helps investors for ways to trade options on CCCC. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for CCCC. It also shows strike prices and maturity days for a C4 Therapeutics against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Open Int | Expiration | Current Spread | Last Price | |||
Call | CCCC Option Call 20-12-2024 3 | 14 | 2024-12-20 | 1.6 - 1.95 | 1.36 | In |
Call | CCCC Option Call 20-12-2024 4 | 52 | 2024-12-20 | 0.0 - 1.05 | 0.5 | In |
Call | CCCC Option Call 20-12-2024 5 | 142 | 2024-12-20 | 0.3 - 0.4 | 0.4 | Out |
Call | CCCC Option Call 20-12-2024 6 | 774 | 2024-12-20 | 0.1 - 0.3 | 0.15 | Out |
Call | CCCC Option Call 20-12-2024 7 | 510 | 2024-12-20 | 0.0 - 0.15 | 0.25 | Out |
Call | CCCC Option Call 20-12-2024 8 | 6 | 2024-12-20 | 0.0 - 0.75 | 0.11 | Out |
Call | CCCC Option Call 20-12-2024 10 | 2 | 2024-12-20 | 0.0 - 0.75 | 0.05 | Out |
Put | CCCC Option Put 20-12-2024 2 | 5 | 2024-12-20 | 0.0 - 0.05 | 0.05 | Out |
Put | CCCC Option Put 20-12-2024 3 | 2079 | 2024-12-20 | 0.0 - 0.1 | 0.1 | Out |
Put | CCCC Option Put 20-12-2024 4 | 308 | 2024-12-20 | 0.0 - 0.25 | 0.13 | Out |
Put | CCCC Option Put 20-12-2024 5 | 25 | 2024-12-20 | 0.5 - 0.7 | 1.45 | In |
Put | CCCC Option Put 20-12-2024 6 | 21 | 2024-12-20 | 1.3 - 1.5 | 1.8 | In |
C4 Therapeutics Market Cap Over Time
Market Cap |
| Timeline |
CCCC Total Stockholder Equity
Total Stockholder Equity |
|
C4 Therapeutics Corporate Management
| Paige Mahaney | Chief Officer | Profile | |
| Kelly Schick | Chief Officer | Profile | |
| Isabel Chiu | Senior Development | Profile | |
| Mr MBA | Chief Officer | Profile | |
| Andrew Hirsch | Pres CEO | Profile | |
| Leonard MD | Chief Officer | Profile |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in C4 Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. For information on how to trade CCCC Stock refer to our How to Trade CCCC Stock guide.You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of C4 Therapeutics. If investors know CCCC will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about C4 Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.71) | Revenue Per Share 0.522 | Quarterly Revenue Growth 0.387 | Return On Assets (0.21) | Return On Equity (0.46) |
The market value of C4 Therapeutics is measured differently than its book value, which is the value of CCCC that is recorded on the company's balance sheet. Investors also form their own opinion of C4 Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is C4 Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because C4 Therapeutics' market value can be influenced by many factors that don't directly affect C4 Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between C4 Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if C4 Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, C4 Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.